{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T00:17:56Z","timestamp":1720916276998},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,12]]},"DOI":"10.7759\/cureus.64441","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T06:56:04Z","timestamp":1720853764000},"source":"Crossref","is-referenced-by-count":0,"title":["Immunohistochemical Analysis of IL-19 and IL-24 Expression in Inflammatory Bowel Disease (IBD) Patients: Results From a Single Center Retrospective Study"],"prefix":"10.7759","author":[{"given":"Alexandros","family":"Toskas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanos","family":"Milias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Delis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soultana","family":"Meditskou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Sioga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Karachrysafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodora","family":"Papamitsou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/348530","article-title":"Potential role of NK cells in the pathogenesis of inflammatory bowel disease","volume":"2011","author":"Yadav PK","year":"2011","unstructured":"Yadav PK, Chen C, Liu Z. Potential role of NK cells in the pathogenesis of inflammatory bowel disease. J Biomed Biotechnol. 2011, 2011:348530. 10.1155\/2011\/348530","journal-title":"J Biomed Biotechnol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020627","article-title":"Interleukin-24 Immunobiology and its roles in inflammatory diseases","volume":"23","author":"Zhong Y","year":"2022","unstructured":"Zhong Y, Zhang X, Chong W. Interleukin-24 Immunobiology and its roles in inflammatory diseases. Int J Mol Sci. 2022, 23:627. 10.3390\/ijms23020627","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11061530","article-title":"Amelioration of murine colitis by attenuated Salmonella choleraesuis encoding interleukin-19","volume":"11","author":"Chen SY","year":"2023","unstructured":"Chen SY, Chu CT, Yang ML, et al.. Amelioration of murine colitis by attenuated Salmonella choleraesuis encoding interleukin-19. Microorganisms. 2023, 11:1530. 10.3390\/microorganisms11061530","journal-title":"Microorganisms"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1153344","article-title":"The colonic interleukin-19 aggravates the dextran sodium sulfate\/stress-induced comorbidities due to colitis and anxiety","volume":"14","author":"Li Q","year":"2023","unstructured":"Li Q, Meng F, Ma X, et al.. The colonic interleukin-19 aggravates the dextran sodium sulfate\/stress-induced comorbidities due to colitis and anxiety. Front Immunol. 2023, 14:1153344. 10.3389\/fimmu.2023.1153344","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0804169","article-title":"Expression of IL-24, an activator of the JAK1\/STAT3\/SOCS3 cascade, is enhanced in inflammatory bowel disease","volume":"183","author":"Andoh A","year":"2009","unstructured":"Andoh A, Shioya M, Nishida A, Bamba S, Tsujikawa T, Kim-Mitsuyama S, Fujiyama Y. Expression of IL-24, an activator of the JAK1\/STAT3\/SOCS3 cascade, is enhanced in inflammatory bowel disease. J Immunol. 2009, 183:687-95. 10.4049\/jimmunol.0804169","journal-title":"J Immunol"},{"key":"ref6","article-title":"Biomarkers in inflammatory bowel diseases: insight into diagnosis, prognosis and treatment","volume":"10","author":"Norouzinia M","year":"2017","unstructured":"Norouzinia M, Chaleshi V, Alizadeh AH, Zali MR. Biomarkers in inflammatory bowel diseases: insight into diagnosis, prognosis and treatment . Gastroenterol Hepatol Bed Bench. 2017, 10:155-67.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12285","article-title":"Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study","volume":"177","author":"Fonseca-Camarillo G","year":"2014","unstructured":"Fonseca-Camarillo G, Furuzawa-Carballeda J, Granados J, Yamamoto-Furusho JK. Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study. Clin Exp Immunol. 2014, 177:64-75. 10.1111\/cei.12285","journal-title":"Clin Exp Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000477","article-title":"Immunoregulatory pathways involved in inflammatory bowel disease","volume":"21","author":"Fonseca-Camarillo G","year":"2015","unstructured":"Fonseca-Camarillo G, Yamamoto-Furusho JK. Immunoregulatory pathways involved in inflammatory bowel disease. Inflamm Bowel Dis. 2015, 21:2188-93. 10.1097\/MIB.0000000000000477","journal-title":"Inflamm Bowel Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajg.2024.01.002","article-title":"The role of IL-19, IL-24, IL-21 and IL-33 in intestinal mucosa of inflammatory bowel disease: a narrative review","author":"Toskas A","year":"2024","unstructured":"Toskas A, Milias S, Papamitsou T, Meditskou S, Kamperidis N, Sioga A. The role of IL-19, IL-24, IL-21 and IL-33 in intestinal mucosa of inflammatory bowel disease: a narrative review. Arab J Gastroenterol. 2024, 10.1016\/j.ajg.2024.01.002","journal-title":"Arab J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.MR1117-471R","article-title":"IL-20 receptor cytokines in autoimmune diseases","volume":"104","author":"Chen J","year":"2018","unstructured":"Chen J, Caspi RR, Chong WP. IL-20 receptor cytokines in autoimmune diseases. J Leukoc Biol. 2018, 104:953-9. 10.1002\/JLB.MR1117-471R","journal-title":"J Leukoc Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2011.08.013","article-title":"Protective role of interleukin-19 gene polymorphisms in patients with ulcerative colitis","volume":"72","author":"Yamamoto-Furusho JK","year":"2011","unstructured":"Yamamoto-Furusho JK, \u00c1lvarez-Le\u00f3n E, Fragoso JM, Gozalishvilli A, Vallejo M, Vargas-Alarc\u00f3n G. Protective role of interleukin-19 gene polymorphisms in patients with ulcerative colitis. Hum Immunol. 2011, 72:1029-32. 10.1016\/j.humimm.2011.08.013","journal-title":"Hum Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000500","article-title":"Genetic markers associated with clinical outcomes in patients with inflammatory bowel disease","volume":"21","author":"Yamamoto-Furusho JK","year":"2015","unstructured":"Yamamoto-Furusho JK, Fonseca-Camarillo G. Genetic markers associated with clinical outcomes in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015, 21:2683-95. 10.1097\/MIB.0000000000000500","journal-title":"Inflamm Bowel Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2018.1503053","article-title":"Advances in understanding the role of cytokines in inflammatory bowel disease","volume":"12","author":"Bevivino G","year":"2018","unstructured":"Bevivino G, Monteleone G. Advances in understanding the role of cytokines in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2018, 12:907-15. 10.1080\/17474124.2018.1503053","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13132185","article-title":"Expression of IL-21 and IL-33 in intestinal mucosa of inflammatory bowel disease: an immunohistochemical study","volume":"13","author":"Toskas A","year":"2023","unstructured":"Toskas A, Milias S, Delis G, Meditskou S, Sioga A, Papamitsou T. Expression of IL-21 and IL-33 in intestinal mucosa of inflammatory bowel disease: an immunohistochemical study. Diagnostics (Basel). 2023, 13:2185. 10.3390\/diagnostics13132185","journal-title":"Diagnostics (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9843-4","article-title":"IL-10-- and IL-20--expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis","volume":"33","author":"Fonseca-Camarillo G","year":"2013","unstructured":"Fonseca-Camarillo G, Furuzawa-Carballeda J, Llorente L, Yamamoto-Furusho JK. IL-10-- and IL-20--expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis. J Clin Immunol. 2013, 33:640-8. 10.1007\/s10875-012-9843-4","journal-title":"J Clin Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02890-7","article-title":"Interleukin-24 regulates mucosal remodeling in inflammatory bowel diseases","volume":"19","author":"\u00d3nody A","year":"2021","unstructured":"\u00d3nody A, Veres-Sz\u00e9kely A, Pap D, et al.. Interleukin-24 regulates mucosal remodeling in inflammatory bowel diseases. J Transl Med. 2021, 19:237. 10.1186\/s12967-021-02890-7","journal-title":"J Transl Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-329628","article-title":"IL-20 controls resolution of experimental colitis by regulating epithelial IFN\/STAT2 signalling","volume":"73","author":"Chiriac MT","year":"2024","unstructured":"Chiriac MT, Hracsko Z, G\u00fcnther C, et al.. IL-20 controls resolution of experimental colitis by regulating epithelial IFN\/STAT2 signalling. Gut. 2024, 73:282-97. 10.1136\/gutjnl-2023-329628","journal-title":"Gut"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00006.2016","article-title":"Interleukin-19 induces angiogenesis in the absence of hypoxia by direct and indirect immune mechanisms","volume":"310","author":"Kako F","year":"2016","unstructured":"Kako F, Gabunia K, Ray M, et al.. Interleukin-19 induces angiogenesis in the absence of hypoxia by direct and indirect immune mechanisms. Am J Physiol Cell Physiol. 2016, 310:C931-41. 10.1152\/ajpcell.00006.2016","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21151","article-title":"Interleukin-19 protects mice from innate-mediated colonic inflammation","volume":"16","author":"Azuma YT","year":"2010","unstructured":"Azuma YT, Matsuo Y, Kuwamura M, et al.. Interleukin-19 protects mice from innate-mediated colonic inflammation. Inflamm Bowel Dis. 2010, 16:1017-28. 10.1002\/ibd.21151","journal-title":"Inflamm Bowel Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700350","article-title":"The stimulation of macrophages with TLR ligands supports increased IL-19 expression in inflammatory bowel disease patients and in colitis models","volume":"199","author":"Steinert A","year":"2017","unstructured":"Steinert A, Linas I, Kaya B, et al.. The stimulation of macrophages with TLR ligands supports increased IL-19 expression in inflammatory bowel disease patients and in colitis models. J Immunol. 2017, 199:2570-84. 10.4049\/jimmunol.1700350","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200425317","article-title":"Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10","volume":"35","author":"Jordan WJ","year":"2005","unstructured":"Jordan WJ, Eskdale J, Boniotto M, Lennon GP, Peat J, Campbell JD, Gallagher G. Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10. Eur J Immunol. 2005, 35:1576-82. 10.1002\/eji.200425317","journal-title":"Eur J Immunol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2015.10.011","article-title":"Interleukin 19 reduces inflammation in chemically induced experimental colitis","volume":"29","author":"Matsuo Y","year":"2015","unstructured":"Matsuo Y, Azuma YT, Kuwamura M, et al.. Interleukin 19 reduces inflammation in chemically induced experimental colitis. Int Immunopharmacol. 2015, 29:468-75. 10.1016\/j.intimp.2015.10.011","journal-title":"Int Immunopharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/201562-immunohistochemical-analysis-of-il-19-and-il-24-expression-in-inflammatory-bowel-disease-ibd-patients-results-from-a-single-center-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T06:56:08Z","timestamp":1720853768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/201562-immunohistochemical-analysis-of-il-19-and-il-24-expression-in-inflammatory-bowel-disease-ibd-patients-results-from-a-single-center-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.64441","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,12]]}}}